Showing results (151-160 of 588) with videos related to

Sort By:
Pageof 59
The Oncologist|August 19, 2018
Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor BiologyGaia Griguolo, Stephane Pouderoux, Maria Vittoria Dieci, et al.
Cytokine|June 21, 2021
Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratificationLoredana Urso, Micol Silic-Benussi, Alice Boscolo, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 11, 2014
Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'?Sara Pilotto, Stefania Kinspergher, Umberto Peretti, et al.
International Journal of Molecular Sciences|November 13, 2020
AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic LimitationsItalia Falcone, Fabiana Conciatori, Chiara Bazzichetto, et al.
Thrombosis Research|June 20, 2006
Major bleedings in the comparisons between low-molecular weight heparin versus oral anticoagulant therapy for venous thromboembolismGianluigi Ferretti, Emilio Bria, Diana Giannarelli, et al.
Breast Cancer Research and Treatment|July 20, 2007
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trialsEmilio Bria, Federica Cuppone, Monica Fornier, et al.
Cancer Treatment and Research Communications|September 11, 2024
The likelihood of being helped or harmed as a patient-centred tool to assess ALK-Inhibitors clinical impact and safety in ALK-addicted non-small cell lung cancer: A systematic review and sensitivity-analysisLuca Mastrantoni, Giulia Giordano, Emanuele Vita, et al.
Carcinogenesis|June 30, 2018
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complexAnastasios Gkountakos, Sara Pilotto, Andrea Mafficini, et al.
Nature Reviews. Clinical Oncology|January 20, 2025
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, et al.
Cancer|January 19, 2006
Adjuvant chemotherapy in muscle-invasive bladder carcinoma: a pooled analysis from phase III studiesEnzo Maria Ruggeri, Diana Giannarelli, Emilio Bria, et al.
Pageof 59